Pay in 4 interest-free payments of $21.25 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
suppressed the emergence of resistance mutations in vitro
InChi: InChI=1S/C17H27NO2/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14/h7-10
differentiation
as well as 38% and 22% in the spleen of untreated mice to undetectale levels
Formula: C13H13N3OS
AZD5363 agillin suppressed the emergence of resistanceAZD5363, also known as Capivasertib, is an orally available inhibitor of the serine threonine protein kinase AKT (protein kinase B) with potential antineoplastic activity. AKT inhibitor AZD5363 binds to and inhibits all AKT isoforms. Inhibition of AKT prevents the phosphorylation of AKT substrates that mediate cellular processes, such as cell division, apoptosis, and glucose and fatty acid metabolism. A wide range of solid and hematological
US$ 15331.79
US$ 17.99
US$ 3815.59
US$ 11.49
US$ 11.49
US$ 13.99
US$ 11.69
US$ 22.19